Musa ÖZTÜRK, Rabia Gökçen GÖZÜBATIK ÇELİK, Fulya BAŞOĞLU KOSEAHMET
Tıp Fakültesi Klinikleri Dergisi
163-167
Multiple-sclerosis, Alemtuzumab, significant side effect, hypertransaminasemia
Multiple-sclerosis, Alemtuzumab, Side effect, Hypertransaminasemia
Mine ARGALI DENİZ, Burcu ÖZÜBERK, Feray CİNEVRE SOYUPEK
Multipl Skleroz Olarak Yanlış Teşhis Edilen Antifosfolipid Sendromu: Bir Olgu Sunumu.
Gülnur TEKGÖL UZUNER, Atilla Özcan ÖZDEMİR, Cengiz KORKMAZ, Nevzat UZUNER
A GENERAL ASSESSMENT ON THE ROLE OF OPPORTUNITY COST IN DECISION MAKING UNDER RISK AND UNCERTAINTY
Turkuaz Uluslararası Sosyo-Ekonomik Stratejik Araştırmalar Dergisi
A Monte-Carlo Simulation for the Estimation of Side-by-Side Loading Events on Oregon Bridges
Arcan YANİK, Christopher HİGGİNS
BAYESIAN NETWORKS FOR SUB-GROUPS OF MULTIPLE SCLEROSIS
International Journal of Electronics Mechanical and Mechatronics Engineering
Turkish Journal of Medical Sciences
Ümit Ali KAYIŞLI, Egemen İDİMAN, İhsan Şükrü ŞENGÜN, Göksemin DEMİR, Necdet DEMİR, Ramazan DEMİR
Restless legs syndrome in multiple sclerosis
Turkish Journal of Medical Sciences
Mine Hayriye SORGUN, Zerin AKSUN, Yahya Burak ATALAY, CANAN YÜCESAN
Current Perspectives in the Pathogenesis and Treatment of Multiple Sclerosis